Key Players
Competitive Landscape
Beta glucan competition separates cereal processors from yeast specialists and functional-ingredient groups that control different source technologies. Yeast specialists differentiate beta-1,3/1,6 structures with immune-health substantiation for commercial nutrition applications. Cereal processors compete on soluble-fiber standardization and claim-ready processing that customers can connect to permitted health claims. Algae-derived suppliers emphasize high-purity beta-1,3 glucan and formulation flexibility for supplements that require comparatively low inclusion levels.
Competitive activity in 2026 has centered on ownership integration and production capacity for yeast-derived functional ingredients. Biorigin became part of Phileo by Lesaffre in July 2026 and brought MacroGard into a larger animal-health organization. Leiber completed the Agsira production-site acquisition in August 2026 to expand dry-yeast capacity in Romania. Both actions expand operational resources available to suppliers serving source-defined yeast beta glucan applications in nutrition.
Company developments mapped to drivers, trends and opportunities (2026-2036)
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| August 2026: Leiber completed its acquisition of the Agsira S.R.L. production site in Romania and expanded dry-yeast capacity. | Yeast-derived ingredient supply depends on reliable fermentation and processing capacity before customers approve recurring commercial orders. | Specialists are adding production capacity nearer European and Balkan customers to shorten supply routes for yeast-based ingredients. | Additional dry-yeast capacity can support shorter regional supply routes for purified yeast beta glucan and related functional ingredients. |
| July 2026: Biorigin announced that it had become part of Phileo by Lesaffre and brought MacroGard into the combined organization. | Animal-nutrition customers require technical and regulatory support that can follow yeast beta-glucan products into multiple species and markets. | Ownership integration is combining specialist yeast products with larger research and regulatory organizations serving animal nutrition. | The combined organization can extend technical support and supply resilience for MacroGard customers in aqua and pet nutrition. |
| April 2026: Lantmännen published a base prospectus confirming ongoing beta-glucan processing at its Kimstad oat biorefinery. | Food manufacturers require stable cereal sourcing and controlled fractionation for claim-relevant oat beta glucan ingredients. | Integrated oat processing keeps beta glucan production close to grain handling and other oat fractionation operations. | The Kimstad platform supports traceable oat-derived ingredient supply for food and supplement formulation customers. |
Kemin and Givaudan compete with algae or oat beta glucan platforms built around human-nutrition applications. Angel Yeast, Biorigin and COSCIENS use yeast or oat routes that differ in source technology and application support.
Source: Future Market Insights, Beta Glucan Market Report, 2026-2036.
Together the group covers cereal and yeast beta glucan alongside algae-derived supply for human nutrition, animal nutrition and selected personal-care applications.
Who leads the beta glucan market?
Kemin and Kerry serve different algae or yeast beta glucan applications with source-specific evidence. Angel Yeast, Givaudan and Lantmännen address other yeast or oat requirements that make direct company-share comparison misleading.
Which companies have documented qualification or quality approvals?
Kemin documents GRAS status and manufacturing controls for BetaVia, while Angel Yeast reports certified yeast beta-glucan production. Leiber has European novel-food history for yeast beta glucan and Biorigin publishes formal quality certifications for MacroGard.
Which companies provide food and supplement beta glucan products?
Kemin and Kerry supply beta glucan ingredients for food or supplement applications with source-specific formulation requirements. Givaudan and Lantmännen focus on oat-derived routes while Angel Yeast, Leiber and COSCIENS cover other yeast or oat applications.
Which companies serve Europe and North America?
Kerry and Kemin document commercial routes in both Europe and North America for beta glucan ingredients. Givaudan and COSCIENS also maintain North American activity while Lantmännen and Leiber document European ingredient supply.
Representative Company Overview
| Company | Positioning | Verified Development |
|---|---|---|
| Kemin Industries Inc. | Algae-derived beta-1,3 glucan supplier for human nutrition with high-purity and water-dispersible BetaVia grades. | February 2026: Kemin updated BetaVia technical guidance covering algae beta-glucan structure, immune support and formulation use. |
| Kerry Group plc | Yeast beta-1,3/1,6 glucan supplier using Wellmune in supplements, functional foods, beverages and pet nutrition. | March 2026: Kerry published an immune-health application update using Wellmune in gummies, shots, stick packs and ready-to-drink formats. |
| Angel Yeast Co., Ltd. | Global yeast company supplying human-health beta glucan and beta-glucan-rich animal-nutrition ingredients. | April 2026: Angel Yeast presented YeaMOS beta-glucan-rich feed solutions at VIV Select India for gut health and immunity applications. |
| Givaudan SA | OatWell supplier offering oat bran ingredients with multiple beta-glucan concentrations for food formulation. | January 2026: Givaudan published its 2025 Integrated Report and identified OatWell within its Taste & Wellbeing portfolio. |
| Lantmännen Biorefineries | Swedish oat processor producing PromOat beta glucan for food, beverage and dietary-supplement applications. | April 2026: Lantmännen published a base prospectus confirming ongoing oat-to-beta-glucan processing at the Kimstad biorefinery. |
| Biorigin, part of Phileo by Lesaffre | Yeast beta-1,3/1,6 glucan supplier focused on MacroGard for aqua, livestock and pet nutrition. | July 2026: Biorigin announced that it had become part of Phileo by Lesaffre with expanded research and regulatory support. |
| COSCIENS Biopharma Inc. (Ceapro Inc.) | Oat active-ingredient platform commercializing oat beta glucan and developing additional yeast beta-glucan applications. | March 2026: COSCIENS filed its annual report identifying beta glucan within Ceapro’s continuing commercial active-ingredient business. |
| Leiber GmbH | Leiber GmbH, owned by Asahi Group Foods since April 2025, supplies high-purity Yestimun beta-1,3/1,6 glucan for human and animal nutrition. | August 2026: Leiber completed the acquisition of the Agsira S.R.L. production site in Romania to expand dry-yeast capacity. |
Research Methodology
The companies mapped here illustrate beta glucan market structure rather than an exhaustive ranking. Inclusion requires current and verifiable evidence that a company supplies source-defined beta glucan or directly processes an immediate beta-glucan ingredient family within the defined market boundary. Regulatory records, company announcements, public filings and technical documentation provide the evidence used for this competitive mapping. Capabilities are attributed to the stated beta glucan platform or ingredient business rather than generalized across broader corporate portfolios. Market-share estimates remain proprietary FMI assessments for the 2026 to 2036 forecast period and are not reproduced in this section.
